Gut hormones: the future of obesity treatment?

被引：21

作者：

McGavigan, Anne K. ^{[1
]}

Murphy, Kevin G. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, Sect Invest Med, London W12 0NN, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2012年 / 74卷 / 06期

基金：

英国生物技术与生命科学研究理事会;

关键词：

glucagon-like peptide-1; gut hormones; obesity; oxyntomodulin; pancreatic polypeptide; peptide YY; GLUCAGON-LIKE PEPTIDE-1; INHIBITS FOOD-INTAKE; REDUCES BODY-WEIGHT; PROOF-OF-CONCEPT; PANCREATIC-POLYPEPTIDE; RECEPTOR AGONISTS; INTRAVENOUS-INFUSION; ENERGY-INTAKE; IN-VITRO; OXYNTOMODULIN;

D O I：

10.1111/j.1365-2125.2012.04278.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Obesity is a major worldwide health problem. The treatment options are severely limited. The development of novel anti-obesity drugs is fraught with efficacy and safety issues. Consequently, several investigational anti-obesity drugs have failed to gain marketing approval in recent years. Anorectic gut hormones offer a potentially safe and viable option for the treatment of obesity. The prospective utility of gut hormones has improved drastically in recent years with the development of longer acting analogues. Additionally, specific combinations of gut hormones have been demonstrated to have additive anorectic effects. This article reviews the current stage of anti-obesity drugs in development, focusing on gut hormone-based therapies.

引用

页码：911 / 919

页数：9

共 50 条

[31] Can Gut Hormones Control Appetite and Prevent Obesity?
Chaudhri, Owais B.
Wynne, Katie
Bloom, Stephen R.
DIABETES CARE, 2008, 31 : S284 - S289
[32] Gut hormones and the treatment of disease cachexia
Ashby, Damien
Choi, Peter
Bloom, Stephen
PROCEEDINGS OF THE NUTRITION SOCIETY, 2008, 67 (03) : 263 - 269
[33] Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota
Mishra, Alok Kumar
Dubey, Vinay
Ghosh, Asit Ranjan
METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (01): : 48 - 65
[34] Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
Schiellerup, Sine Paasch
Skov-Jeppesen, Kirsa
Windelov, Johanne Agerlin
Svane, Maria Saur
Holst, Jens Juul
Hartmann, Bolette
Rosenkilde, Mette Marie
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[35] Thyroid hormones in the pathogenesis and treatment of obesity
Krotkiewski, M
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) : 85 - 98
[36] Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones
Daniele, G.
Dardano, A.
Lunghi, C.
Giusti, L.
Ciccarone, A.
Santini, F.
Ceccarini, G.
Bellini, R.
Moretto, C.
Miccoli, R.
Penno, G.
Morrone, M.
Del Prato, S.
DIABETOLOGIA, 2018, 61 : S71 - S71
[37] The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity
Chrysi Koliaki
Stavros Liatis
Maria Dalamaga
Alexander Kokkinos
Current Obesity Reports, 2020, 9 : 255 - 271
[38] The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity
Koliaki, Chrysi
Liatis, Stavros
Dalamaga, Maria
Kokkinos, Alexander
CURRENT OBESITY REPORTS, 2020, 9 (03) : 255 - 271
[39] Obesity-related gut hormones and cancer: novel insight into the pathophysiology
Maria Angela Guzzardi
Gabriella Pugliese
Filomena Bottiglieri
Caterina Pelosini
Giovanna Muscogiuri
Luigi Barrea
Silvia Savastano
Annamaria Colao
International Journal of Obesity, 2021, 45 : 1886 - 1898
[40] Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery
Hoist, Jens Juul
CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (06) : 983 - 988

← 1 2 3 4 5 →